Open AccessFavipiravir Induced Acute Pancreatitis in a COVID-19 Patient
Author(s) -
Ahm Ejrarul Alam Khan,
M M Hoque,
Uzzwal Mallik,
Kamalesh Chandra Basu,
Mohammed Masudul Hasan,
Imran Mahmud,
Mirza Mohammad Asif Adnan,
Mujibur Rahman
Publication year - 2021
Publication title -
journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.121
H-Index - 5
eISSN - 2075-5384
pISSN - 1997-9797
DOI - 10.3329/jom.v22i1.51396
Subject(s) - medicine , favipiravir , acute pancreatitis , pancreatitis , asymptomatic , covid-19 , gastroenterology , disease , intensive care medicine , infectious disease (medical specialty)
There are a number of gastrointestinal symptoms and complications of COVID-19. Asymptomatic increase in pancreatic enzymes and rarely symptomatic pancreatitis are observed in this disease. This article describes a 37-year-old male suffering from mildly symptomatic COVID-19 infection, who received tablet favipiravir for his management. His condition was improving, when he developed acute pancreatitis, diagnosed clinically, biochemically and also with help of abdominal ultrasound. When he developed this, all typical symptoms of COVID-19 were improved. As a result, role of favipiravir in the development of this pancreatitis was suspected.
J MEDICINE JAN 2021; 22 (1) : 69-71